Wearable-based certification of a premises as contagion-safe
Due to the many interactions that can occur in places of gatherings, such as workplaces, schools, theaters, etc., these locations can be considered dangerous to enter during times of epidemics. It is difficult to keep track of the health state of all the people who visited a location, and thus ascertain if visits to the location pose any risk of contracting a disease. Some embodiments disclosed herein utilize wearable devices that measure physiological signals of their wearer in order to determine whether people who were at a location were healthy, and thus be able to certify the location as contagion-safe.
1. A system configured to certify a premises as contagion-safe, comprising:
wearable devices configured to take measurements of users wearing the wearable devices utilizing first sensors configured to measure first signals indicative of photoplethysmogram signals and second sensors configured to measure second signals indicative of temperatures; and
a computer configured to:
calculate health scores of the users based on at least some of the first and second signals taken while the users were not on the premises;
identify which of the users are non-symptomatic users based on their health scores reaching a threshold;
authenticate identities of the non-symptomatic users; and
certify the premises as contagion-safe responsive to determining that, from among the users, only non-symptomatic users, whose authentication was successful, entered the premises during a predetermined period.
2. The system of claim 1 , further comprising a user interface configured to notify a non-symptomatic user that said non-symptomatic user is allowed on the premises.
3. The system of claim 1 , wherein the computer is further configured to identify some of the users as symptomatic users based on their measurements taken while not on the premises; and further comprising a user interface configured to notify the symptomatic users, prior to their arriving to the premises, that they are not allowed on the premises.
4. The system of claim 1 , wherein each at least some of the first sensors are contact photoplethysmogram sensors, at least some of the second sensors are contact temperature sensors, and the authentication of identities of at least some of the non-symptomatic users is based at least in part on their photoplethysmogram signals.
5. The system of claim 1 , wherein the wearable devices further comprise acoustic sensors configured to take audio recordings of the users; and the computer is further configured to utilize, in calculation of a health score of a certain user from among the users, an extent of coughing recognizable in the audio recordings of the certain user.
6. The system of claim 1 , wherein the computer is further configured to receive identities of at least some of the users who arrived at the premises and to determine, based on the identities, whether a user, who is not among the non-symptomatic users, entered the premises.
7. The system of claim 1 , wherein the computer is further configured to: identify some of the users as symptomatic users based on their health scores reaching the threshold, and decertify the premises as contagion-safe responsive to detecting that a symptomatic user entered the premises after the predetermined period.
8. The system of claim 7 , wherein the computer is further configured to receive an indication of a time when the symptomatic user left the premises, and to re-certify the premises as contagion-safe after a predetermined duration from that time.
9. The system of claim 1 , wherein the computer is further configured to identify that a person not wearing one of the wearable devices (a non-cleared person) entered the premises after the predetermined period, and decertify the premises as contagion-safe responsive to detecting that the non-cleared person entered the premises.
10. The system of claim 1 , wherein the computer is further configured to identify, after the predetermined period, that a user on the premises became ill, and decertify the premises as contagion-safe.
11. The system of claim 1 , wherein the health scores are calculated with respect to a certain disease, and certification of the premises as contagion-safe is indicative that only non-symptomatic users with respect to the certain disease, whose authentication was successful, entered the premises during the predetermined period.
12. The system of claim 11 , wherein the computer is further configured to confirm, based on external medical records, immunity of one or more people who had the certain disease and to refrain from decertifying the premises due to their entry to the premises during the predetermined period.
13. A system configured to certify a premises as contagion-safe, comprising:
wearable devices configured to take measurements of users wearing the wearable devices utilizing first sensors configured to measure first signals indicative of photoplethysmogram signals and second sensors configured to measure second signals indicative of temperatures; and
a computer configured to:
calculate health scores of the users based on at least some of the first and second signals taken while the users were not on the premises;
identify which of the users are non-symptomatic users based on their health scores reaching a threshold;
authenticate identities of the non-symptomatic users; and
certify the premises as contagion-safe responsive to determining that the non-symptomatic users whose authentication was successful comprise at least a certain predetermined proportion of all of the users who visited the premises.
14. The system of claim 13 , further comprising a user interface configured to present an indication proportional to at least one of percent and/or density of the following: the non-symptomatic users in the premises, symptomatic users in the premises, and users for which symptom status is unknown; whereby the presented indications support decision of other users whether to visit the premises at that time; and wherein the authentication of identities of at least some of the non-symptomatic users is based at least in part on their photoplethysmogram signals.
15. The system of claim 14 , wherein the computer is further configured to receive location of a certain user in the premises, and recommend the certain user use certain personal protection equipment based on the indication proportional to the at least one of the percent and/or the density.
16. A method for certifying a premises as contagion-safe, comprising:
receiving measurements of users measured with wearable devices while the users were not on the premises; wherein the measurements are taken utilizing first sensors configured to measure first signals indicative of photoplethysmogram signals and second sensors configured to measure second signals indicative of temperatures;
calculating health scores of the users based on the measurements;
identifying which of the users are non-symptomatic users based on their health scores reaching a threshold;
authenticating identities of the non-symptomatic users; and
certifying the premises as contagion-safe responsive to determining that, from among the users, only non-symptomatic users, whose authentication was successful, entered the premises during a predetermined period.
17. The method of claim 16 , further comprising notifying the non-symptomatic users that they are allowed on the premises; and further comprising: confirming, based on external medical records, immunity of one or more people who had a certain disease, and refraining from decertifying the premises due to their entry to the premises during the predetermined period.
18. The method of claim 16 , further comprising: identifying some of the users as symptomatic users based on their measurements measured while not on the premises, and notifying the symptomatic users, prior to their arriving to the premises, that they are not allowed on the premises; and wherein authentication of identities of at least some of the symptomatic users is based at least in part on their photoplethysmogram signals.
19. The method of claim 16 , further comprising: identifying some of the users as symptomatic users based on their health scores being below the threshold, and decertifying the premises as contagion-safe responsive to detecting that a symptomatic user entered the premises after the predetermined period.
20. The method of claim 16 , further comprising: identifying, after the predetermined period, that a user on the premises became ill, and decertifying the premises as contagion-safe.